ID   DNMT1_RAT               Reviewed;        1622 AA.
AC   Q9Z330; P70487; Q9R252; Q9WTX3; Q9WU57;
DT   21-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2002, sequence version 2.
DT   02-OCT-2024, entry version 186.
DE   RecName: Full=DNA (cytosine-5)-methyltransferase 1;
DE            Short=Dnmt1;
DE            EC=2.1.1.37;
DE   AltName: Full=DNA MTase RnoIP;
DE            Short=M.RnoIP;
DE   AltName: Full=DNA methyltransferase I;
DE   AltName: Full=MCMT;
GN   Name=Dnmt1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, and Placenta;
RX   PubMed=9878564; DOI=10.1006/bbrc.1998.9802;
RA   Kimura H., Takeda T., Tanaka S., Ogawa T., Shiota K.;
RT   "Expression of rat DNA (cytosine-5) methyltransferase (DNA MTase) in rodent
RT   trophoblast giant cells: molecular cloning and characterization of rat DNA
RT   MTase.";
RL   Biochem. Biophys. Res. Commun. 253:495-501(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 1-144 (ISOFORMS 1 AND 9).
RC   TISSUE=Brain;
RA   Deng J., Szyf M.;
RT   "Multiple N-terminal isoforms of DNA (cytosine-5-)-methyltransferase in
RT   vivo.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 17-356, AND IN VITRO BINDING TO ANNEXIN V.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=8667030; DOI=10.1046/j.1471-4159.1996.67010089.x;
RA   Ohsawa K., Imai Y., Ito D., Kohsaka S.;
RT   "Molecular cloning and characterization of annexin V-binding proteins with
RT   highly hydrophilic peptide structure.";
RL   J. Neurochem. 67:89-97(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1169-1517 (ISOFORMS 1; 2; 3; 4; 5; 6;
RP   7 AND 8).
RX   PubMed=9722504; DOI=10.1074/jbc.273.36.22869;
RA   Deng J., Szyf M.;
RT   "Multiple isoforms of DNA methyltransferase are encoded by the vertebrate
RT   cytosine DNA methyltransferase gene.";
RL   J. Biol. Chem. 273:22869-22872(1998).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15; THR-304; SER-718 AND
RP   SER-1436, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Methylates CpG residues. Preferentially methylates
CC       hemimethylated DNA. Associates with DNA replication sites in S phase
CC       maintaining the methylation pattern in the newly synthesized strand,
CC       that is essential for epigenetic inheritance. Associates with chromatin
CC       during G2 and M phases to maintain DNA methylation independently of
CC       replication. It is responsible for maintaining methylation patterns
CC       established in development. DNA methylation is coordinated with
CC       methylation of histones. Mediates transcriptional repression by direct
CC       binding to HDAC2. In association with DNMT3B and via the recruitment of
CC       CTCFL/BORIS, involved in activation of BAG1 gene expression by
CC       modulating dimethylation of promoter histone H3 at H3K4 and H3K9.
CC       Probably forms a corepressor complex required for activated KRAS-
CC       mediated promoter hypermethylation and transcriptional silencing of
CC       tumor suppressor genes (TSGs) or other tumor-related genes in
CC       colorectal cancer (CRC) cells. Also required to maintain a
CC       transcriptionally repressive state of genes in undifferentiated
CC       embryonic stem cells (ESCs). Associates at promoter regions of tumor
CC       suppressor genes (TSGs) leading to their gene silencing. Promotes tumor
CC       growth. {ECO:0000250|UniProtKB:P26358}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxycytidine in DNA + S-adenosyl-L-methionine = a 5-
CC         methyl-2'-deoxycytidine in DNA + H(+) + S-adenosyl-L-homocysteine;
CC         Xref=Rhea:RHEA:13681, Rhea:RHEA-COMP:11369, Rhea:RHEA-COMP:11370,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789,
CC         ChEBI:CHEBI:85452, ChEBI:CHEBI:85454; EC=2.1.1.37;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10018};
CC   -!- SUBUNIT: Homodimer. Forms a stable complex with E2F1, BB1 and HDAC1.
CC       Forms a complex with DMAP1 and HDAC2, with direct interaction.
CC       Interacts with the PRC2/EED-EZH2 complex. Probably part of a
CC       corepressor complex containing ZNF304, TRIM28, SETDB1 and DNMT1.
CC       Interacts with UHRF1; promoting its recruitment to hemimethylated DNA.
CC       Interacts with USP7, promoting its deubiquitination. Interacts with
CC       PCNA. Interacts with MBD2 and MBD3. Interacts with DNMT3A and DNMT3B.
CC       Interacts with UBC9 (By similarity). Interacts with CSNK1D (By
CC       similarity). Interacts with HDAC1 (By similarity). Interacts with
CC       BAZ2A/TIP5 (By similarity). Interacts with SIRT7 (By similarity).
CC       Interacts with ZNF263; recruited to the SIX3 promoter along with other
CC       proteins involved in chromatin modification and transcriptional
CC       corepression where it contributes to transcriptional repression (By
CC       similarity). Interacts with L3MBTL3 and DCAF5; the interaction requires
CC       DNMT1 methylation at Lys-139 and is necessary to target DNMT1 for
CC       ubiquitination by the CRL4-DCAF5 E3 ubiquitin ligase complex and
CC       proteasomal degradation (By similarity). Interacts with PHF20L1; the
CC       interaction requires DNMT1 methylation at Lys-139 and protects DNMT1
CC       from ubiquitination and proteasomal degradation (By similarity).
CC       {ECO:0000250|UniProtKB:P13864, ECO:0000250|UniProtKB:P26358}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=9;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9Z330-1; Sequence=Displayed;
CC       Name=2; Synonyms=SF1;
CC         IsoId=Q9Z330-2; Sequence=VSP_005627;
CC       Name=3; Synonyms=SF2;
CC         IsoId=Q9Z330-3; Sequence=VSP_005625;
CC       Name=4; Synonyms=SF3;
CC         IsoId=Q9Z330-4; Sequence=VSP_005624;
CC       Name=5; Synonyms=SF4;
CC         IsoId=Q9Z330-5; Sequence=VSP_005621;
CC       Name=6; Synonyms=SF5;
CC         IsoId=Q9Z330-6; Sequence=VSP_005622;
CC       Name=7; Synonyms=SF6;
CC         IsoId=Q9Z330-7; Sequence=VSP_005626;
CC       Name=8; Synonyms=SF7;
CC         IsoId=Q9Z330-8; Sequence=VSP_005623;
CC       Name=9; Synonyms=short;
CC         IsoId=Q9Z330-9; Sequence=VSP_005620;
CC   -!- TISSUE SPECIFICITY: Isoforms 0 and 8 are highly expressed in placenta,
CC       brain, lung, spleen, kidney, heart, and at much lower levels in liver.
CC       Isoform 1 is expressed in cerebellum, isoform 2 in muscle and testis,
CC       isoform 3 in lung, isoform 4 in spleen and brain, and isoform 5 in
CC       brain.
CC   -!- DOMAIN: The N-terminal part is required for homodimerization and acts
CC       as a regulatory domain.
CC   -!- DOMAIN: The CXXC-type zinc finger specifically binds to unmethylated
CC       CpG dinucleotides, positioning the autoinhibitory linker between the
CC       DNA and the active site, thus providing a mechanism to ensure that only
CC       hemimethylated CpG dinucleotides undergo methylation.
CC       {ECO:0000250|UniProtKB:P26358}.
CC   -!- PTM: Sumoylated; sumoylation increases activity.
CC       {ECO:0000250|UniProtKB:P26358}.
CC   -!- PTM: Acetylation on multiple lysines, mainly by KAT2B/PCAF, regulates
CC       cell cycle G(2)/M transition. Deacetylation of Lys-1116 and Lys-1354 by
CC       SIRT1 increases methyltransferase activity.
CC       {ECO:0000250|UniProtKB:P26358}.
CC   -!- PTM: Phosphorylation of Ser-151 by CDKs is important for enzymatic
CC       activity and protein stability. Phosphorylation of Ser-140 by AKT1
CC       prevents methylation by SETD7 therebye increasing DNMT1 stability.
CC       {ECO:0000250|UniProtKB:P26358}.
CC   -!- PTM: Methylation at Lys-139 by SETD7 is necessary for the regulation of
CC       DNMT1 proteasomal degradation. {ECO:0000250|UniProtKB:P26358}.
CC   -!- PTM: Ubiquitinated by UHRF1; interaction with USP7 counteracts
CC       ubiquitination by UHRF1 by promoting deubiquitination and preventing
CC       degradation by the proteasome. {ECO:0000250|UniProtKB:P13864}.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding methyltransferase
CC       superfamily. C5-methyltransferase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01016}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB012214; BAA37118.1; -; mRNA.
DR   EMBL; AF116344; AAD32541.1; -; mRNA.
DR   EMBL; AF116345; AAD32542.1; -; Genomic_DNA.
DR   EMBL; D64060; BAA20854.1; -; mRNA.
DR   EMBL; AH007612; AAD28102.1; -; Genomic_DNA.
DR   PIR; JE0378; JE0378.
DR   AlphaFoldDB; Q9Z330; -.
DR   SMR; Q9Z330; -.
DR   IntAct; Q9Z330; 2.
DR   STRING; 10116.ENSRNOP00000063831; -.
DR   REBASE; 11410; M.RraDnmtI.
DR   REBASE; 3019; M.RnoDnmt1.
DR   CarbonylDB; Q9Z330; -.
DR   iPTMnet; Q9Z330; -.
DR   PhosphoSitePlus; Q9Z330; -.
DR   jPOST; Q9Z330; -.
DR   PaxDb; 10116-ENSRNOP00000063831; -.
DR   UCSC; RGD:620979; rat. [Q9Z330-1]
DR   AGR; RGD:620979; -.
DR   RGD; 620979; Dnmt1.
DR   eggNOG; ENOG502QPKK; Eukaryota.
DR   InParanoid; Q9Z330; -.
DR   PhylomeDB; Q9Z330; -.
DR   BioCyc; MetaCyc:MONOMER-8581; -.
DR   BRENDA; 2.1.1.37; 5301.
DR   Reactome; R-RNO-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-RNO-4655427; SUMOylation of DNA methylation proteins.
DR   PRO; PR:Q9Z330; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0001674; C:female germ cell nucleus; ISO:RGD.
DR   GO; GO:0043073; C:germ cell nucleus; ISO:RGD.
DR   GO; GO:0000792; C:heterochromatin; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0005721; C:pericentric heterochromatin; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0005657; C:replication fork; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0003886; F:DNA (cytosine-5-)-methyltransferase activity; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0009008; F:DNA-methyltransferase activity; ISO:RGD.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:RGD.
DR   GO; GO:0106222; F:lncRNA binding; ISO:RGD.
DR   GO; GO:0008327; F:methyl-CpG binding; ISO:RGD.
DR   GO; GO:0008168; F:methyltransferase activity; ISO:RGD.
DR   GO; GO:0030331; F:nuclear estrogen receptor binding; IPI:RGD.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISS:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0003723; F:RNA binding; ISO:RGD.
DR   GO; GO:0008757; F:S-adenosylmethionine-dependent methyltransferase activity; TAS:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISO:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISO:RGD.
DR   GO; GO:1903926; P:cellular response to bisphenol A; ISO:RGD.
DR   GO; GO:0071284; P:cellular response to lead ion; IEP:RGD.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEP:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IMP:RGD.
DR   GO; GO:0141119; P:chromosomal DNA methylation maintenance following DNA replication; ISO:RGD.
DR   GO; GO:0006346; P:DNA methylation-dependent heterochromatin formation; ISO:RGD.
DR   GO; GO:0006351; P:DNA-templated transcription; ISO:RGD.
DR   GO; GO:0043045; P:epigenetic programming of gene expression; ISO:RGD.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0044027; P:negative regulation of gene expression via chromosomal CpG island methylation; IDA:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:1905460; P:negative regulation of vascular associated smooth muscle cell apoptotic process; ISO:RGD.
DR   GO; GO:1905931; P:negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; IEP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0097305; P:response to alcohol; IEP:RGD.
DR   GO; GO:0031000; P:response to caffeine; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0010212; P:response to ionizing radiation; IEP:RGD.
DR   GO; GO:0010288; P:response to lead ion; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0033574; P:response to testosterone; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0033189; P:response to vitamin A; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:RGD.
DR   CDD; cd04760; BAH_Dnmt1_I; 1.
DR   CDD; cd04711; BAH_Dnmt1_II; 1.
DR   Gene3D; 1.10.10.2230; -; 1.
DR   Gene3D; 2.30.30.490; -; 2.
DR   Gene3D; 3.90.120.10; DNA Methylase, subunit A, domain 2; 1.
DR   Gene3D; 3.40.50.150; Vaccinia Virus protein VP39; 1.
DR   InterPro; IPR001025; BAH_dom.
DR   InterPro; IPR043151; BAH_sf.
DR   InterPro; IPR050390; C5-Methyltransferase.
DR   InterPro; IPR018117; C5_DNA_meth_AS.
DR   InterPro; IPR001525; C5_MeTfrase.
DR   InterPro; IPR031303; C5_meth_CS.
DR   InterPro; IPR022702; Cytosine_MeTrfase1_RFD.
DR   InterPro; IPR010506; DMAP1-bd.
DR   InterPro; IPR017198; DNMT1-like.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   InterPro; IPR002857; Znf_CXXC.
DR   PANTHER; PTHR10629; CYTOSINE-SPECIFIC METHYLTRANSFERASE; 1.
DR   PANTHER; PTHR10629:SF52; DNA (CYTOSINE-5)-METHYLTRANSFERASE 1; 1.
DR   Pfam; PF01426; BAH; 2.
DR   Pfam; PF06464; DMAP_binding; 1.
DR   Pfam; PF00145; DNA_methylase; 1.
DR   Pfam; PF12047; DNMT1-RFD; 1.
DR   Pfam; PF02008; zf-CXXC; 1.
DR   PIRSF; PIRSF037404; DNMT1; 1.
DR   PRINTS; PR00105; C5METTRFRASE.
DR   SMART; SM00439; BAH; 2.
DR   SMART; SM01137; DMAP_binding; 1.
DR   SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1.
DR   PROSITE; PS51038; BAH; 2.
DR   PROSITE; PS00094; C5_MTASE_1; 1.
DR   PROSITE; PS00095; C5_MTASE_2; 1.
DR   PROSITE; PS51912; DMAP1_BIND; 1.
DR   PROSITE; PS51679; SAM_MT_C5; 1.
DR   PROSITE; PS51058; ZF_CXXC; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Chromatin regulator;
KW   DNA-binding; Isopeptide bond; Metal-binding; Methylation;
KW   Methyltransferase; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; S-adenosyl-L-methionine; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..1622
FT                   /note="DNA (cytosine-5)-methyltransferase 1"
FT                   /id="PRO_0000088036"
FT   DOMAIN          16..109
FT                   /note="DMAP1-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01260"
FT   DOMAIN          759..884
FT                   /note="BAH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00370"
FT   DOMAIN          977..1105
FT                   /note="BAH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00370"
FT   REPEAT          1114..1115
FT                   /note="1"
FT   REPEAT          1116..1117
FT                   /note="2"
FT   REPEAT          1118..1119
FT                   /note="3"
FT   REPEAT          1120..1121
FT                   /note="4"
FT   REPEAT          1122..1123
FT                   /note="5"
FT   REPEAT          1124..1125
FT                   /note="6"
FT   REPEAT          1126..1127
FT                   /note="7; approximate"
FT   DOMAIN          1144..1603
FT                   /note="SAM-dependent MTase C5-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01016"
FT   ZN_FING         650..696
FT                   /note="CXXC-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   REGION          1..342
FT                   /note="Interaction with the PRC2/EED-EZH2 complex"
FT                   /evidence="ECO:0000250"
FT   REGION          1..145
FT                   /note="Interaction with DNMT3A"
FT                   /evidence="ECO:0000250"
FT   REGION          100..360
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          146..213
FT                   /note="Interaction with DNMT3B"
FT                   /evidence="ECO:0000250"
FT   REGION          304..610
FT                   /note="Interaction with the PRC2/EED-EZH2 complex"
FT                   /evidence="ECO:0000250"
FT   REGION          327..556
FT                   /note="DNA replication foci-targeting sequence"
FT   REGION          697..758
FT                   /note="Autoinhibitory linker"
FT   REGION          702..733
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1099..1138
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1114..1127
FT                   /note="7 X 2 AA tandem repeats of K-G"
FT   REGION          1126..1622
FT                   /note="Interaction with the PRC2/EED-EZH2 complex"
FT                   /evidence="ECO:0000250"
FT   REGION          1144..1622
FT                   /note="Catalytic"
FT   MOTIF           173..200
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        144..168
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        171..224
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        232..328
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1124..1138
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        1231
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01016,
FT                   ECO:0000255|PROSITE-ProRule:PRU10018"
FT   BINDING         359
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         362
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         420
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         424
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250"
FT   BINDING         657
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         660
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         663
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         668
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         671
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         674
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         690
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         695
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00509"
FT   BINDING         1151
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:P13864"
FT   BINDING         1155..1156
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:P13864"
FT   BINDING         1173..1174
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   BINDING         1195..1196
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:P13864"
FT   BINDING         1196
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   BINDING         1582
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   BINDING         1584
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:P13864"
FT   SITE            515
FT                   /note="Important for activity"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         70
FT                   /note="N6,N6-dimethyllysine; by EHMT2"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         138
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13864"
FT   MOD_RES         139
FT                   /note="N6-methyllysine; by SETD7"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         140
FT                   /note="Phosphoserine; by PKB/AKT1"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         149
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         151
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         163
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         169
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         304
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         372
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         400
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         515
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13864"
FT   MOD_RES         555
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         718
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         736
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         753
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         882
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         895
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         961
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         980
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         1116
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         1118
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         1120
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         1122
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         1124
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P13864"
FT   MOD_RES         1126
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P13864"
FT   MOD_RES         1354
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   MOD_RES         1436
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CROSSLNK        1613
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P26358"
FT   VAR_SEQ         1..118
FT                   /note="Missing (in isoform 9)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005620"
FT   VAR_SEQ         1202..1410
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005622"
FT   VAR_SEQ         1216..1504
FT                   /note="Missing (in isoform 8)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005623"
FT   VAR_SEQ         1218..1430
FT                   /note="QKGDVEMLCGGPPCQGFSGMNRFNSRTYSKFKNSLVVSFLSYCDYYRPRFFL
FT                   LENVRNFVSFRRSMVLKLTLRCLVRMGYQCTFGVLQAGQYGVAQTRRRAIILAAAPGEK
FT                   LPLFPEPLHVFAPRACQLSVVVDDKKFVSNITRLSSGPFRTITMRDTMSDLPEIQNGAS
FT                   APEISYKWRATVLVPEAAARVALPAHPQGPYPQVHERAGGCRM -> VC (in
FT                   isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005621"
FT   VAR_SEQ         1226..1477
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005624"
FT   VAR_SEQ         1252..1482
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005625"
FT   VAR_SEQ         1259..1481
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005626"
FT   VAR_SEQ         1323..1403
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005627"
FT   CONFLICT        17..25
FT                   /note="AGSLPDHVR -> RQARPRPCP (in Ref. 3; BAA20854)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        189
FT                   /note="A -> V (in Ref. 3; BAA20854)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1276
FT                   /note="F -> S (in Ref. 1; BAA37118)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1300
FT                   /note="T -> I (in Ref. 4; AAD28102)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1372
FT                   /note="M -> V (in Ref. 1; BAA37118)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1394..1428
FT                   /note="KWRATVLVPEAAARVALPAHPQGPYPQVHERAGGC -> NGEPQSWFQRQLR
FT                   GSHYQPILRDHICKDMSALVAA (in Ref. 1; BAA37118)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1622 AA;  182774 MW;  FCFA4AAA69E234BA CRC64;
     MPARTAPARV PALASPAGSL PDHVRRRLKD LERDGLTEKE CVKEKLNLLH EFLQTEIKSQ
     LCDLETKLHK EELSEEGYLA KVKTLLNKDL CLENGTLSLT QKANGCPANG SRPTWKAEMA
     DSNRSPRSRP KPRGPRRSKS DSETMIEASS SSVATRRTTR QTTITSHFKG PAKRKPKEDS
     EKGNANESAA EERDQDKKRR VAGTESRASR AGESVEKPER VRPGTQLCQE EQGEQEDDRR
     PRRQTRELAS RRKSREDPDR EARPGTHLDV DDDDEKDKRS SRPRSQPRDL ATKRRPKEEV
     EQITPEPPEG KDEDEREEKR RKTTRKKPEP LSIPVQSRVE RKASQGKASA IPKLNPPQCP
     ECGQYLDDPD LKYQQHPVDA VDEPQMLTNE ALSVFDSNSS WFETYDSSPM HKFTFFSVYC
     SRGHLCPVDT GLIEKNVELY FSGVAKAIHE ENPSVEGGVN GKNLGPINQW WISGFDGGEK
     ALIGFSTAFA EYFLMEPSPE YAPIFGLMQE KIYISKIVVE FLQSNPDAVY EDLINKIETT
     VPPSAINVNR FTEDSLLRHA QFVVSQVESY DDAKDDDETP IFLSPCMRSL IHLAGVSLGQ
     RRATRRTVIN SAKVKRKGPT KATTTKLVYQ IFDTFFSEQI EKDDKEDKEN TMKRRRCGVC
     EVCQQPECGK CKACKDMVKF GGTGRSKQAC LKRRCPNLAV KEADEDEEAD DDIPELPSPK
     KLHQGKKKKQ NKDRISWLGE PVKIEENRTY YWKVSIDEET LEVGDCVSVI PDDPSKPLYL
     ARVTALWEDK NGQMFHAHWF CAGTDTVLGA TSDPLELFLV GECENMQLSY IHSKVKVIYR
     GPSPNWAMEG GMDPEAMLPG AEDGKTYFYQ FWYSQDYARF ESPPKTQPAE DNKHKFCLSC
     IRLAELRQKE MPKVLEQLEE VDGRVYCSSI TKNGVVYRLG DSVYLPPEAF TFNIKMASPM
     KRSKRDPVNE NPVPRDTYRK YSDYIKGSNL DAPEPYRIGR IKEIYCGKKK GGKVNEADIK
     IRLYKFYRPE NTHKSIQATY HADINLLYWS DEEAVVDFSD VQGRCTVEYG EDLLESIQDY
     SQGGPDRFYF LEAYNSKTKS FEDPPNHARS PGNKGKGKGK GKGKGKPQVS EPKEPEAAIK
     LPKLRTLDVF SGCGGLTEGF HQAGISETLW AIEMWEPAAQ AFRLNNPGTT VFTEDCNVLL
     KLVMAGEVTN SLGQRLPQKG DVEMLCGGPP CQGFSGMNRF NSRTYSKFKN SLVVSFLSYC
     DYYRPRFFLL ENVRNFVSFR RSMVLKLTLR CLVRMGYQCT FGVLQAGQYG VAQTRRRAII
     LAAAPGEKLP LFPEPLHVFA PRACQLSVVV DDKKFVSNIT RLSSGPFRTI TMRDTMSDLP
     EIQNGASAPE ISYKWRATVL VPEAAARVAL PAHPQGPYPQ VHERAGGCRM RHIPLSPGSD
     WRDLPNIQVR LRDGVITNKL RYTFHDTKNG CSSTGALRGV CSCAEGKTCD PASRQFNTLI
     PWCLPHTGNR HNHWAGLYGR LEWDGFFSTT VTNPEPMGKQ GRVLHPEQHR VVSVRECARS
     QGFPDTYRLF GNILDRHRQV GNAVPPPLAK AIGLEIKLCL LASAQESASA AVKGKEETTT
     ED
//
